Ignite Creation Date:
2024-10-25 @ 8:03 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06610188
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-09-19
Brief Title:
The Effect of Inulin in Irritable Bowel Syndrome
Sponsor:
None
Organization:
None
Study Overview
Official Title:
The Effect of Inulin on Intestinal Symptoms Depression and Quality of Life in Individuals With Constipation-Predominant Irritable Bowel Syndrome
Status:
COMPLETED
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Purpose This study was conducted to evaluate the effect of inulin on bowel symptoms depression and quality of life in individuals with constipation-dominant irritable bowel syndrome Individuals n34 aged 21-63 years with constipation-dominant IBS were included in the study Individuals were divided into two groups as prebiotic group n17 inulinoligofructose 5050 mixture of 46 g Inulintotal 92 g inulinoligofructose 5050 mixture twice a day and placebo n17 Maltodextrin92 g group The intervention period was 8 weeks and Bristol Stool Scale IBS-Visual Analogue Scale IBS-Symptom Severity Score Scale IBS-SSS IBS-Quality of Life Scale IBS-QoL and Beck Depression Scale were administered to the participants at the beginning 1st month and 2nd month SPSS software programme was used for statistical analysis of the data It is thought that inulin supplementation may be effective in reducing symptom severity and frequency improving bowel function stool frequency consistency and transit time and quality of life and thus may be beneficial in individuals with constipation-predominant IBS
Detailed Description:
In the treatment of IBS a multimodel perspective that includes psychological support cognitive behavioural therapy stress management techniques etc in addition to lifestyle changes dietary changes etc may be beneficial
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None